Publications

  1. Fang P, Jacobson MS, Hung JC. Influential Factors in the Preparation of (68)Ga-DOTATATE. J Nucl Med Technol. 2020 Sep; 48 (3):263-268 Epub 2020 Apr 10
    View PubMed
  2. Bornholdt MG, Woelfel KM, Fang P, Jacobson MS, Hung JC. Rapid Instant Thin-Layer Chromatography System for Determining the Radiochemical Purity of (68)Ga-DOTATATE. J Nucl Med Technol. 2018 Sep; 46 (3):285-287 Epub 2018 May 03
    View PubMed
  3. Markovic SN, Galli F, Suman VJ, Nevala WK, Paulsen AM, Hung JC, Gansen DN, Erickson LA, Marchetti P, Wiseman GA, Signore A. Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study. Oncotarget. 2018 Jul 13; 9(54):30268-30278.
    View PubMed
  4. Filzen LM, Ellingson LR, Paulsen AM, Hung JC. Potential Ways to Address Shortage Situations of 99Mo/99mTc. J Nucl Med Technol. 2017 Mar; 45(1):1-5. Epub 2017 Feb 02.
    View PubMed
  5. Michenfelder MM, Bartlett LJ, Mahoney DW, Herold TJ, Hung JC. Particle-size and radiochemical purity evaluations of filtered 99mTc-sulfur colloid prepared with different heating times. J Nucl Med Technol. 2014 Dec; 42: (4)283-8.
    View PubMed
  6. Hung JC. Bringing New PET drugs to clinical practice - a regulatory perspective. Theranostics. 2013 Nov 1; 3 (11):885-93 Epub 2013 Nov 01
    View PubMed
  7. Mitchell CR, Lowe VJ, Rangel LJ, Hung JC, Kwon ED, Karnes RJ. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. J Urol. 2013 Apr; 189 (4):1308-13 Epub 2012 Oct 30
    View PubMed
  8. Long JZ, Jacobson MS, Hung JC. Comparison of FASTlab 18F-FDG production using phosphate and citrate buffer cassettes. J Nucl Med Technol. 2013 Mar; 41(1):32-4. Epub 2013 Jan 14.
    View PubMed
  9. Schwarz S, Norenberg J, Berridge M, Dragotakes S, Hung J, Link J, Mason NS, Mattmuller S, Nickel RA, Packard A, Paolino J, Petry N, Ponto J, Quinton TM, Seifert KL, Swanson D, Weiner RE, Zigler S. The future of USP monographs for PET drugs. J Nucl Med. 2013 Mar; 54: (3)472-5.
    View PubMed
  10. Hegseth KM, Warren AM, Hung JC, Mosman EA. Evaluation of compatibility and stability of filtered 99mTc-sulfur colloid when combined with fluorescent indocyanine green dye. J Nucl Med Technol. 2012 Sep; 40(3):194-7. Epub 2012 Jun 07.
    View PubMed
  11. Hakala JL, Hung JC, Mosman EA. Minimizing human error in radiopharmaceutical preparation and administration via a bar code-enhanced nuclear pharmacy management system. J Nucl Med Technol. 2012 Sep; 40 (3):183-6 Epub 2012 June 05
    View PubMed
  12. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, Rybin D, Liu CT, Bielak LF, Prokopenko I, Amin N, Barnes D, Cadby G, Hottenga JJ, Ingelsson E, Jackson AU, Johnson T, Kanoni S, Ladenvall C, Lagou V, Lahti J, Lecoeur C, Liu Y, Martinez-Larrad MT, Montasser ME, Navarro P, Perry JR, Rasmussen-Torvik LJ, Salo P, Sattar N, Shungin D, Strawbridge RJ, Tanaka T, van Duijn CM, An P, de Andrade M, Andrews JS, Aspelund T, Atalay M, Aulchenko Y, Balkau B, Bandinelli S, Beckmann JS, Beilby JP, Bellis C, Bergman RN, Blangero J, Boban M, Boehnke M, Boerwinkle E, Bonnycastle LL, Boomsma DI, Borecki IB, Bottcher Y, Bouchard C, Brunner E, Budimir D, Campbell H, Carlson O, Chines PS, Clarke R, Collins FS, Corbaton-Anchuelo A, Couper D, de Faire U, Dedoussis GV, Deloukas P, Dimitriou M, Egan JM, Eiriksdottir G, Erdos MR, Eriksson JG, Eury E, Ferrucci L, Ford I, Forouhi NG, Fox CS, Franzosi MG, Franks PW, Frayling TM, Froguel P, Galan P, de Geus E, Gigante B, Glazer NL, Goel A, Groop L, Gudnason V, Hallmans G, Hamsten A, Hansson O, Harris TB, Hayward C, Heath S, Hercberg S, Hicks AA, Hingorani A, Hofman A, Hui J, Hung J, Jarvelin MR, Jhun MA, Johnson PC, Jukema JW, Jula A, Kao WH, Kaprio J, Kardia SL, Keinanen-Kiukaanniemi S, Kivimaki M, Kolcic I, Kovacs P, Kumari M, Kuusisto J, Kyvik KO, Laakso M, Lakka T, Lannfelt L, Lathrop GM, Launer LJ, Leander K, Li G, Lind L, Lindstrom J, Lobbens S, Loos RJ, Luan J, Lyssenko V, Magi R, Magnusson PK, Marmot M, Meneton P, Mohlke KL, Mooser V, Morken MA, Miljkovic I, Narisu N, O'Connell J, Ong KK, Oostra BA, Palmer LJ, Palotie A, Pankow JS, Peden JF, Pedersen NL, Pehlic M, Peltonen L, Penninx B, Pericic M, Perola M, Perusse L, Peyser PA, Polasek O, Pramstaller PP, Province MA, Raikkonen K, Rauramaa R, Rehnberg E, Rice K, Rotter JI, Rudan I, Ruokonen A, Saaristo T, Sabater-Lleal M, Salomaa V, Savage DB, Saxena R, Schwarz P, Seedorf U, Sennblad B, Serrano-Rios M, Shuldiner AR, Sijbrands EJ, Siscovick DS, Smit JH, Small KS, Smith NL, Smith AV, Stancakova A, Stirrups K, Stumvoll M, Sun YV, Swift AJ, Tonjes A, Tuomilehto J, Trompet S, Uitterlinden AG, Uusitupa M, Vikstrom M, Vitart V, Vohl MC, Voight BF, Vollenweider P, Waeber G, Waterworth DM, Watkins H, Wheeler E, Widen E, Wild SH, Willems SM, Willemsen G, Wilson JF, Witteman JC, Wright AF, Yaghootkar H, Zelenika D, Zemunik T, Zgaga L, DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Multiple Tissue Human Expression Resource (MUTHER) Consortium, Wareham NJ, McCarthy MI, Barroso I, Watanabe RM, Florez JC, Dupuis J, Meigs JB, Langenberg C. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet. 2012 Jun; 44(6):659-69. Epub 2012 May 13.
    View PubMed
  13. Walters LR, Martin KJ, Jacobson MS, Hung JC, Mosman EA. Stability evaluation of (18)F-FDG at high radioactive concentrations. J Nucl Med Technol. 2012 Mar; 40(1):52-6. Epub 2012 Feb 7.
    View PubMed
  14. Hung JC, Schwarz SW, Zigler SS, Ravichandran R. Revision of USP general chapter radiopharmaceuticals for positron emission tomography-compounding <823>. Pharmacopeial Forum. 2011; 37(1).
  15. USP PET Radiopharmaceuticals Ad Hoc Advisory Panel (including Hung JC). <823> Positron emission tomography drugs for compounding, investigational, and research uses. Pharmacopeial Forum. 2011; 37(1).
  16. Eggert LA, Dick MD, Mahoney DW, Olson JP, Werner GL, Hung JC. A rapid radiochemical purity testing method for 99mTc-tetrofosmin. J Nucl Med Technol. 2010 Jun; 38 (2):81-4 Epub 2010 May 18
    View PubMed
  17. Hung JC. The exploratory IND (phase 0) concept. Annals of Nuclear Medicine and Sciences. 2009; 22:93-100.
  18. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M, American Society of Echocardiography, European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009 Jan; 22(1):1-23; quiz 101-2.
    View PubMed
  19. Hung JC, Anderson MM. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy. J Nucl Med. 2009 Jan; 50(1):156-64. Epub 2008 Dec 17.
    View PubMed
  20. Dewhirst CA, Hung JC. Comparison of the EZ-Cap recapper with the Mayo recapper for the prevention of needlesticks. J Nucl Med Technol. 2008 Sep; 36(3):151-4. Epub 2008 Aug 14.
    View PubMed
  21. Schultz MK, Cessna JT, Anderson TL, Ponto JA, Petry N, Kowalsky RJ, Palmer MR, Beinlich UF, Baker W, Hinkle GH, Hung JC, Quinton T, Rice PA, Divgi C, Norenberg JP. A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States. Appl Radiat Isot. 2008 Feb; 66(2):252-60. Epub 2007 Sep 18.
    View PubMed
  22. Jensen PF, Hung JC. Safety devices for delivery of radioactive iodine. Health Phys. 2008 Jan; 94(1):67-70.
    View PubMed
  23. Mroczenski AA, Berent SM, Hall AA, Hung JC, Herold TJ, Mullan BP. Trends of radiopharmaceutical use at Mayo Clinic Rochester. J Nucl Med Technol. 2007 Sep; 35(3):154-8. Epub 2007 Aug 16.
    View PubMed
  24. Hung JC. In-process 20-minute endotoxin "limit test" for positron emission tomography radiopharmaceuticals. J Am Pharm Assoc (2003). 2006 Jan-Feb; 46 (1):89-92
    View PubMed
  25. Hung JC, Iverson BC, Jacobson MS, Mahoney DW. Inhibition evaluation for a 20-min endotoxin limit test on FDG. Nucl Med Commun. 2005 Oct; 26 (10):869-74
    View PubMed
  26. Hung JC, Lenz WN, Reed TL, McGough CG. A cost-effective and versatile xenon gas dispenser. Nucl Med Commun. 2005 Apr; 26 (4):383-6
    View PubMed
  27. Hung JC, Ponto JA, Gadient KR, Frie JA, Aksamit CM, Enquist CL, Carrels KE. Deficiencies of product labeling directions for the preparation of radiopharmaceuticals. J Am Pharm Assoc (2003). 2004 Jan-Feb; 44 (1):30-5
    View PubMed
  28. Hung JC. Comparison of various requirements of the quality assurance procedures for (18)F-FDG injection. J Nucl Med. 2002 Nov; 43(11):1495-506.
    View PubMed
  29. Hung JC, Augustine SC, Cheng KT, Green RL, Hopkins WM, Laven DL, Nelson BR, Petry NA, Ponto JA, Quinton TM, Swanson DP. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines. J Am Pharm Assoc (Wash). 2002 Sep-Oct; 42 (5):789-98
    View PubMed
  30. Forstrom LA, Dunn WL, Mullan BP, Hung JC, Lowe VJ, Thorson LM. Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects. Nucl Med Commun. 2002 Aug; 23 (8):721-5
    View PubMed
  31. Hung JC, Iverson BC, Toulouse KA, Mahoney DW. Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes. J Nucl Med. 2002 Jul; 43(7):928-32.
    View PubMed
  32. Hung JC, Toulouse KA, Iverson BC, Mahoney DW. Comparison of two inhouse formulations of technetium Tc 99m albumin. Am J Health Syst Pharm. 2002 May 15; 59 (10):964-7
    View PubMed
  33. Jacobson MS, Hung JC, Mays TL, Mullan BP. The planning and design of a new PET radiochemistry facility. Mol Imaging Biol. 2002 Mar; 4 (2):119-27
    View PubMed
  34. Hung JC, Toulouse KA, Iverson BC, Mahoney DW. A comparison of two formulations and a complete chromatography method for the in-house preparation of 99mTc-lableled human serum albumin. American Journal of Health-System Pharmacists. 2002; 59(10):964-7.
  35. Hung JC, Gadient KR, Mahoney DW, Murray JA. In-house preparation of technetium 99m-labeled human serum albumin for evaluation of protein-losing gastroenteropathy. J Am Pharm Assoc (Wash). 2002 Jan-Feb; 42 (1):57-62
    View PubMed
  36. Hung JC. "Yellow eluate" from a 99mTc generator. J Nucl Med. 2001 May; 42(5):827-9.
    View PubMed
  37. Hung JC. Regulation of the compounding of positron emission tomography drugs. Am J Health Syst Pharm. 2001 Jan 15; 58 (2):134-9
    View PubMed
  38. Hung JC. Pharmacy compounding practice & the current law. Florida Pharmacy Today. 2001; 65(10):9.
  39. Luebke AL, Wilary DM, Mahoney DW, Hung JC. Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi. J Nucl Med Technol. 2000 Dec; 28(4):259-63.
    View PubMed
  40. Hung JC, Mahoney DW, Huang DC, Wang A. The relationship between elution time and eluate volume using the Ultra-TechneKow DTE technetium-99m generator. J Nucl Med Technol. 2000 Sep; 28 (3):178-81
    View PubMed
  41. Forstrom LA, Mullan BP, Hung JC, Lowe VJ, Thorson LM. 18F-FDG labelling of human leukocytes. Nucl Med Commun. 2000 Jul; 21 (7):691-4
    View PubMed
  42. Robins PD, Salazar I, Forstrom LA, Mullan BP, Hung JC. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects. J Nucl Med. 2000 May; 41(5):934-40.
    View PubMed
  43. Hung JC, Redfern MG, Mahoney DW, Thorson LM, Wiseman GA. Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. J Am Pharm Assoc (Wash). 2000 Jan-Feb; 40 (1):46-51
    View PubMed
  44. Hung JC, Jacobson MS. Commentary on the current regulations of compounded PET drugs in the United States. Annals of Nuclear Medicine and Sciences. 2000; 13(1):49-55.
  45. Ponto JA, Hung JC. Nuclear pharmacy, part II: nuclear pharmacy practice today. Journal of Nuclear Medicine Technology. 2000; 28(2):76-81.
    View PubMed
  46. Mosman EA, Peterson LJ, Hung JC, Gibbons RJ. Practical methods for reducing radioactive contamination incidents in the nuclear cardiology laboratory. J Nucl Med Technol. 1999 Dec; 27(4):287-9.
    View PubMed
  47. Hung JC, Krause SJ, Schmit CL. Sensible approaches to avoid needle stick accidents in nuclear medicine. J Nucl Med Technol. 1999 Dec; 27(4):290-3.
    View PubMed
  48. McGough CG, Huang DC, Hung JC. Comparison of four 1-mL syringes for administering first-pass radionuclide angiography doses. J Nucl Med Technol. 1999 Sep; 27(3):227-9.
    View PubMed
  49. Bogsrud TV, Herold TJ, Mahoney DW, Hung JC. Comparison of three cold kit reconstitution techniques for the reduction of hand radiation dose. Nucl Med Commun. 1999 Aug; 20 (8):761-7
    View PubMed
  50. Johnston DL, Scanlon PD, Hodge DO, Glynn RB, Hung JC, Gibbons RJ. Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease. Mayo Clin Proc. 1999 Apr; 74: (4)339-46.
    View PubMed
  51. O'Brien TJ, Brinkmann BH, Mullan BP, So EL, Hauser MF, O'Connor MK, Hung J, Jack CR. Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis. J Neurol Neurosurg Psychiatry. 1999 Mar; 66 (3):331-9
    View PubMed
  52. Bogsrud TV, Chen MN, Herold TJ, Mahoney DW, Hung JC. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals. Nucl Med Commun. 1999 Jan; 20 (1):61-5
    View PubMed
  53. Hung JC, Chowdhury S, Mahoney DW, Mullan BP. Radiolabelled mixed leukocytes and pure granulocytes with stabilized 99Tcm-exametazime. Nucl Med Commun. 1998 Oct; 19 (10):981-7
    View PubMed
  54. Hung JC, Chowdhury S, Mullan BP. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes. J Nucl Med. 1998 May; 39(5):912-7.
    View PubMed
  55. Mullan BP, Camilleri M, Hung JC. Activated charcoal as a potential radioactive marker for gastrointestinal studies. Nucl Med Commun. 1998 Mar; 19 (3):237-40
    View PubMed
  56. Hung JC, Mahoney DW, Johnston DL, Gibbons RJ. An optimal dual-size vial system for the cost-effective usage of Adenoscan. J Nucl Cardiol. 1998 Mar-Apr; 5 (2):161-6
    View PubMed
  57. Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med. 1997 Nov; 38: (11)1807-10.
    View PubMed
  58. Bush CR, Coughlin JE, Herold TJ, Hung JC. Faster and easier radiochemical purity testing for [125I]sodium iothalamate. Nucl Med Biol. 1997 Jul; 24 (5):479-83
    View PubMed
  59. Hung JC, Chowdhury S, Redfern MG, Mahoney DW. Rapid preparation method for technetium-99m bicisate. Eur J Nucl Med. 1997 Jun; 24 (6):655-9
    View PubMed
  60. Hung JC. Radioiodine dispensing and usage in a centralized hospital nuclear pharmacy. Thyroid. 1997 Apr; 7(2):289-94.
    View PubMed
  61. Owens TP, Hung JC, Glynn RB, Forstrom LA, Johnston DL, O'Connor MK, Mullan BP. Technical aspects of an outreach mobile nuclear medicine service. J Nucl Med Technol. 1997; 25:155.
  62. Mullan BP, O'Connor MK, Hung JC. Single photon emission computed tomography brain imaging. Neurosurg Clin N Am. 1996 Oct; 7: (4)617-51.
    View PubMed
  63. Hung JC, Ponto JA, Hammes RJ. Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med. 1996 Oct; 26 (4):208-55
    View PubMed
  64. Hung JC. A comparison of current regulations and regulatory guide governing quality control of dose calibrators. Health Phys. 1996 Aug; 71 (2):206-10
    View PubMed
  65. Hung JC, Herold TJ, Gibbons RJ. Optimal conditions of 99mTc eluate for the radiolabeling of 99mTc-sestamibi. Nucl Med Biol. 1996 Jul; 23 (5):599-603
    View PubMed
  66. Waite SD, Hung JC. Positive patient and sample identification for blood radiolabeling procedures with a bar code system. J Nucl Med Technol. 1996; 24(1):39-44.
  67. Helton JD, Barron TL, Hung JC. Criteria for determining optimal pediatric dosage for a diagnostic nuclear medicine procedure. J Nucl Med Technol. 1996; 24(1):35-38.
  68. Mullan BP, O'Connor MK, Hung JC. Single photon emission computed tomography. Neuroimaging Clin N Am. 1995 Nov; 5 (4):647-73
    View PubMed
  69. Hung JC, Herold TJ, Wilson ME, Gibbons RJ. Generator eluate effects on the labeling efficiency of 99mTc-sestamibi. Nucl Med Biol. 1995 Oct; 22 (7):949-51
    View PubMed
  70. Hung JC, Wiseman GA, Wahner HW, Mullan BP, Taggart TR, Dunn WL. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med. 1995 Oct; 36: (10)1895-901.
    View PubMed
  71. Budde PA, Hung JCY, Mahoney DW, Wollan PC. Rapid quality control procedure for technetium-99m-bicisate. J Nucl Med Technol. 1995 Sep; 23:190-194.
  72. Hung JCY. Dose measurements for Sr-89 chloride injections. Health Phys. 1995 Sep; 69:420-421.
    View PubMed
  73. Thorson LM, Turkalj A, Hung JC. In vitro evaluation of neutrophil viability after exposure to a hypotonic medium. Nucl Med Commun. 1995 Jul; 16 (7):615-20
    View PubMed
  74. Hung JC. Dose measurement for 89Sr chloride injection. Health Phys. 1995 Apr; 68 (4):571
    View PubMed
  75. Hung JC, Thorson LM. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3. Nucl Med Commun. 1995 Mar; 16(3):157-60.
    View PubMed
  76. Hung JC, Wilson ME, Gebhard MW, Gibbons RJ. Comparison of four alternative radiochemical purity testing methods for 99Tcm-sestamibi. Nucl Med Commun. 1995 Feb; 16 (2):99-104
    View PubMed
  77. Hung JC, Budde PA, Wilson ME. Testing the radiochemical purity of technetium Tc 99m-labeled radiopharmaceuticals. Am J Health Syst Pharm. 1995 Feb 1; 52 (3):310-3
    View PubMed
  78. Hung JC, Wilson ME. Rapid radiochemical purity testing for [131I]m-iodobenzylguanidine. Nucl Med Biol. 1995 Feb; 22 (2):227-9
    View PubMed
  79. Owens TP, Hung JC, Glynn RB, Gibbons RJ. Assessment of cardiac stress tests. J Nucl Med Technol. 1995; 23(4):267-70.
  80. Owens TP, Hung JCY. The effect of job duties in contributing to radiation exposure of the nuclear medicine technologist. J Nucl Med Technol. 1995; 23:87-90.
  81. Herold TJ, Gross GP, Hung JCY. A technique for measurement of strontium-89 in a dose calibrator. J Nucl Med Technol. 1995; 23:26-28.
  82. Thorson LM, Turkalj A, Hung JC. Evaluation of a how single-gradient, Ficoll-Hypaque with hypotonic lysis method for leukocyte separation. J Nucl Med Technol. 1995; 23(4):282-288.
  83. Hollar BS, Hung JCY, Hauser MF. Evaluation of the microwave heating technique as an alternative method for preparing technetium-99-sulfur colloid. J Nucl Med Technol. 1995; 23:77-81.
  84. Hung JC. The packaging of the light-sensitive cold kits. Journal of Nuclear Medicine Technology. 1995; 23(3):215-6.
  85. Herold TJ, Gross GP, Hung JC. Reply to Dell MA, Porter WC, Eck L. A technique for measurement of strontium-89 in a dose calibrator Journal of Nuclear Medicine Technology. 1995; 23(3):218.
  86. Hung JC, Wilson ME. Optimal volume of anticoagulant citrate dextrose solution in the preparation of technetium Tc 99m-labeled red blood cells. Am J Hosp Pharm. 1994 Nov 1; 51(21):2699-701.
    View PubMed
  87. Hung JC, Herold TJ. Modified radioiodination and quality control methods for [125I]sodium iothalamate. Nucl Med Biol. 1994 Oct; 21 (7):1011-2
    View PubMed
  88. Hung JC, Taggart TR, Wilson ME, Owens TP. Radiochemical purity testing for 99Tcm-exametazime: a comparison study for three-paper chromatography. Nucl Med Commun. 1994 Jul; 15 (7):569-74
    View PubMed
  89. Brown ML, Hung JC, Vetter RJ, O'Connor MK, Chowdhury S, Forstrom LA. The radiation dosimetry and normal value study of 99mTc-HMPAO-labeled leukocytes. Invest Radiol. 1994 Apr; 29 (4):443-7
    View PubMed
  90. Glynn RB, Narveson LG, Hung JCY, Gibbons RJ. Adjustment to radionuclide angiogram dose based upon patient's physical parameters. J Nucl Med Technol. 1994; 22:17-20.
  91. Glynn RB, Narveson LG, Hung JCY, Gibbons RY. Radionuclide angiogram dose adjustment based upon patient physical parameters. J Nucl Med Technol. 1994; 22:17-20.
  92. Wieseler JF, Gebhard MW, Hung JCY, Mullan BP, Wilson ME. In vivo comparison of anticoagulant citrate dextrose versus heparin for use as an anticoagulant with the Ultratag (Trademark) red blood cell kit. J Nucl Med Technol. 1994; 22:178-181.
  93. Wilson ME, Hung JC. Microwave preparation of and one-strip paper chromatography for technetium Tc 99m teboroxime. Am J Hosp Pharm. 1993 Nov; 50(11):2376-9.
    View PubMed
  94. Wilson ME, Hung JC, Gibbons RJ. An alternative method for rapid preparation of 99Tcm-sestamibi. Nucl Med Commun. 1993 Jul; 14 (7):544-9
    View PubMed
  95. Brown ML, O'Connor MK, Hung JC, Hayostek RJ. Technical aspects of bone scintigraphy. Radiol Clin North Am. 1993 Jul; 31(4):721-30.
    View PubMed
  96. Chowdhury S, Hung JCY. Optimal centrifugation: parameters for labeling efficiency determination of technetium-99m labeled red blood cells. (Posterboard no. 1603). J Nucl Med Technol. 1993 Jun; 21:114.
  97. Herold TJ, Hung JCY. Modified radiolabeling method for sodium iothalamate I-125. (Posterboard no. 1620). J Nucl Med Technol. 1993 Jun; 21:118-119.
  98. Kvols LK, Brown ML, O'Connor MK, Hung JC, Hayostek RJ, Reubi JC, Lamberts SW. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology. 1993 Apr; 187: (1)129-33.
    View PubMed
  99. Oswald WM, Wilson ME, Herold TJ, Hung JCY. Utilization of a bar-code system in a nuclear pharmacy. J Nucl Med Technol. 1993 Mar; 21:27-32.
  100. Patterson E, Buros RD, Hung JCY, Scherlag BJ. Coronary vascular injury after transient coronary artery occlusion. Lab Invest. 1993; 69:471-482.
    View PubMed
  101. Larcos G, McLarty AJ, McGregor CG, Brown ML, Brown ML, Hung JC, O'Connor MK, Tazelaar HD. Evaluation of 99Tcm nonspecific polyclonal IgG in the detection of rejection in a single lung transplant canine model. Nucl Med Commun. 1993 Jan; 14 (1):64-9
    View PubMed
  102. Bolstad DM, Valley TB, Wilson ME, Hung JCY. An improved technique for reducing the number of particles in a technetium-99m macroaggregated albumin injection. J Nucl Med Technol. 1992 Dec; 20:220-223.
  103. Thorson LM, Hung JC, Hollar BS. Feasibility of fractionating MAG3 cold kit for cost reduction. Nucl Med Commun. 1992 Nov; 13 (11):832-7
    View PubMed
  104. O'Connor MK, Kvols LK, Brown ML, Hung JC, Hayostek RJ, Cho DS, Vetter RJ. Dosimetry and biodistribution of an iodine-123-labeled somatostatin analog in patients with neuroendocrine tumors. J Nucl Med. 1992 Sep; 33: (9)1613-9.
    View PubMed
  105. Oswald WM, Herold TJ, Wilson ME, Hung JCY. Dose calibrator linearity testing using an improved attenuator system. J Nucl Med Technol. 1992; 20:169-172.
  106. Hung JC, Lenz WN, Wilson ME, Valley TB. Modification of the vial/syringe holder for the dose calibrator. Journal of Nuclear Medicine Technology. 1992; 20(4):245-6.
  107. O'Connor MK, Brown ML, Hung JC, Hayostek RJ. The art of bone scintigraphy--technical aspects. J Nucl Med. 1991 Dec; 32: (12)2332-41.
    View PubMed
  108. Hung JC, Wilson ME, Brown ML, Gibbons RJ. Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi). J Nucl Med. 1991 Nov; 32: (11)2162-8.
    View PubMed
  109. Hung JCY, Wilson ME, Brown ML. Rapid preparation and quality control of technetium-99m meriatide (99mTc-MAG3). J Nucl Med Technol. 1991; 19:176-179.
  110. Hung JCY, Volkert WA, Holmes RA. Stabilization of technetium-99m-d, 1-hexamethylpropyleneamineoxime (Tc-99m-d, 1-hmpao) using gentisic acid. Nucl Med Biol. 1989; 16:675-680.
  111. Hung JC, Corlija M, Volkert WA, Holmes RA. Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media. J Nucl Med. 1988 Sep; 29(9):1568-76.
    View PubMed
  112. Hu CY, Hung JCY, Robinson CP. The effect of soman on vascular contractility of rabbit arteries. J Toxicol Environ Health. 1988; 24:201-215.
    View PubMed
  113. Hu CY, Hung JCY, Robinson CP. Effects of daily soman administration on rabbit blood pressure, temperature, body weight, erythrocyte and plasma cholinesterases. Bull Environ Contam Toxicol. 1988; 40:365-372.
    View PubMed
  114. Hung JCY, Burow RD, Scherlag BJ, Basmadjian GP, Lazzara R. New method for measuring myocardial blood flow by high-resolution scintigraphy in the excised dog heart. J Nucl Med. 1986 Oct; 27(10):1586-1592.
    View PubMed
  115. Hung JCY. The relationship between blood flow, tissue viability, and lethal ventricular arrhythmias in the infarcted dog heart. Dissertation (Phd),. 1985;